Figure 4
Cell viability (%) of MRC5 normal cell lines treated with various concentrations (5–100 μg/mL) of compounds 1–6 and cisplatin vs cells treated in DMSO (0.1%).
Figure 4 | Scientific Reports
Cell viability (%) of MRC5 normal cell lines treated with various concentrations (5–100 μg/mL) of compounds 1–6 and cisplatin vs cells treated in DMSO (0.1%).
